AustralianSuper Pty Ltd Makes New $15.74 Million Investment in Aveanna Healthcare Holdings Inc. $AVAH

AustralianSuper Pty Ltd acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,774,837 shares of the company’s stock, valued at approximately $15,743,000. AustralianSuper Pty Ltd owned about 0.85% of Aveanna Healthcare at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. raised its stake in shares of Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock valued at $35,850,000 after buying an additional 1,041,324 shares during the period. Hillsdale Investment Management Inc. purchased a new stake in shares of Aveanna Healthcare in the 3rd quarter valued at about $7,922,000. Assenagon Asset Management S.A. bought a new stake in Aveanna Healthcare during the third quarter valued at approximately $7,356,000. First Eagle Investment Management LLC lifted its holdings in shares of Aveanna Healthcare by 12.1% during the 2nd quarter. First Eagle Investment Management LLC now owns 810,667 shares of the company’s stock worth $4,240,000 after acquiring an additional 87,500 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of Aveanna Healthcare by 103.9% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 664,890 shares of the company’s stock worth $3,477,000 after purchasing an additional 338,746 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on AVAH shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. Truist Financial raised their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. William Blair assumed coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They issued an “outperform” rating on the stock. Barclays lifted their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Finally, Zacks Research downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Five research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $11.06.

Aveanna Healthcare Stock Down 2.0%

AVAH opened at $7.28 on Wednesday. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The stock has a market cap of $1.52 billion, a price-to-earnings ratio of 20.22 and a beta of 2.07. The firm’s fifty day moving average is $8.22 and its 200 day moving average is $8.55.

Insider Activity at Aveanna Healthcare

In related news, CFO Matthew Buckhalter sold 13,512 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $97,421.52. Following the transaction, the chief financial officer directly owned 529,243 shares of the company’s stock, valued at approximately $3,815,842.03. The trade was a 2.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Edwin C. Reisz sold 60,769 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $438,144.49. Following the sale, the insider directly owned 1,447,057 shares of the company’s stock, valued at approximately $10,433,280.97. This trade represents a 4.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 998,595 shares of company stock worth $7,567,770 in the last three months. Corporate insiders own 7.00% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.